These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 7998074)

  • 1. At(a-) phenotype: description of a family and reduced survival of At(a+) red cells in a proposita with anti-Ata.
    Sweeney JD; Holme S; McCall L; Huett D; Storry J; Reid M
    Transfusion; 1995 Jan; 35(1):63-7. PubMed ID: 7998074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on the blood of a Co (a-b-) proposita and her family.
    Lacey PA; Robinson J; Collins ML; Bailey DG; Evans CC; Moulds JJ; Daniels GL
    Transfusion; 1987; 27(3):268-71. PubMed ID: 3590290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Augustine blood group system, 48 years in the making.
    Daniels G
    Immunohematology; 2016 Sep; 32(3):100-103. PubMed ID: 27834482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of maternal antibody anti-Jra on the baby: a case report and pedigree chart.
    Takabayashi T; Murakami M; Yajima H; Tsujiei M; Ozawa N; Yajima A
    Tohoku J Exp Med; 1985 Jan; 145(1):97-101. PubMed ID: 3983961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of anti-At(a).
    Ramsey G; Sherman LA; Zimmer AM; Spies WG; Sharma L; Arndt P; Garratty G
    Vox Sang; 1995; 69(2):135-7. PubMed ID: 8585195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A clinically significant erythrocyte antibody detectable only by 51Cr survival studies.
    Baldwin ML; Barrasso C; Ness PM; Garratty G
    Transfusion; 1983; 23(1):40-4. PubMed ID: 6402832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe delayed hemolytic transfusion reaction secondary to anti-At(a).
    Cash KL; Brown T; Sausais L; Uehlinger J; Reed LJ
    Transfusion; 1999 Aug; 39(8):834-7. PubMed ID: 10504118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemolytic transfusion reaction due to anti-Tc(a).
    Kowalski MA; Pierce SR; Edwards RL; Ethirajan S; Ryan K; Livergood MP
    Transfusion; 1999 Sep; 39(9):948-50. PubMed ID: 10533820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-Ata causing mild hemolytic disease of the newborn.
    Culver PL; Brubaker DB; Sheldon RE; Martin M; Richter CA
    Transfusion; 1987; 27(6):468-70. PubMed ID: 3686655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 51Chromium survival of Yt(a+) red cells as a determinant of the in vivo significance of anti-Yta.
    Davey RJ; Simpkins SS
    Transfusion; 1981; 21(6):702-5. PubMed ID: 7314218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinically significant allo-anti-I in an I-negative patient with massive hemorrhage.
    Chaplin H; Hunter VL; Malecek AC; Kilzer P; Rosche ME
    Transfusion; 1986; 26(1):57-61. PubMed ID: 3946005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Some observations on the Inb antigen and evidence that anti-Inb causes accelerated destruction of radiolabeled red cells.
    Ferguson DJ; Gaal HD
    Transfusion; 1988; 28(5):479-82. PubMed ID: 3420678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimation of transfused red cell survival using an enzyme-linked antiglobulin test.
    Kickler TS; Smith B; Bell W; Drew H; Baldwin M; Ness PM
    Transfusion; 1985; 25(5):401-5. PubMed ID: 4049483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-JMH identified in serum and in eluate from red cells of a JMH-negative man.
    Whitsett CF; Moulds M; Pierce JA; Hare V
    Transfusion; 1983; 23(4):344-5. PubMed ID: 6410552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo studies of the long-term 51Cr red cell survival of serologically incompatible red cell units.
    Baldwin ML; Ness PM; Barrasso C; Kickler TS; Drew H; Tsan MF; Shirey RS
    Transfusion; 1985; 25(1):34-8. PubMed ID: 3969699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of the clinical significance of anti-Dob.
    Shirey RS; Boyd JS; King KE; Caturegli PP; Montgomery WM; Ness PM
    Transfusion; 1998; 38(11-12):1026-9. PubMed ID: 9838932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival of Kn(a+) McC(a+) red cells in a patient with anti- "Kna/McCa".
    Ballas SK; Viggiano E; Draper EK
    Transfusion; 1984; 24(1):22-4. PubMed ID: 6695436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transient anti-Gya in an untransfused man. Serologic characteristics and cell survival study.
    Ellisor SS; Reid ME; Avoy DR; Toy PT; Mecoli J
    Transfusion; 1982; 22(2):166-8. PubMed ID: 7071923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased fetal erythropoiesis and hemolysis in Kell hemolytic anemia.
    Weiner CP; Widness JA
    Am J Obstet Gynecol; 1996 Feb; 174(2):547-51. PubMed ID: 8623782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An example of anti-Yta demonstrating a change in its clinical significance.
    AuBuchon JP; Brightman A; Anderson HJ; Kim B
    Vox Sang; 1988; 55(3):171-5. PubMed ID: 3238951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.